Administration Core The Administration Core of the Michigan Diabetes Research Center (MDRC) provides leadership, infrastructure, and resources to: ? Raise awareness of, interest in, and support for research in diabetes, its complications and related endocrine and metabolic disorders and create an environment that facilitates such research. ? Coordinate the activities of the MDRC and provide guidance and coordination to the support for diabetes research at the UM and its regional partners ? Recruit new investigators to diabetes research and the MDRC, and support new and established investigators in diabetes research. ? Administer Cores that provide MDRC members with expertise and services to support diabetes related research. ? Administer the MDRC Pilot and Feasibility Study (P/FS) Grants Programs. ? Provide enrichment, education, and training for investigators from diverse schools, departments, and institutes to foster interdisciplinary collaborations. ? Maintain the Center's website.

Public Health Relevance

Diabetes and its complications are enormous clinical and public health problems. The MDRC provides researchers with expertise and shared resources to enhance biomedical and clinical research to prevent, treat, and ultimately cure diabetes and its complications. The Administration Core guides and oversees the provision of resources to enhance the productivity, efficiency, and cost-effectiveness of multidisciplinary and collaborative research related to diabetes.

National Institute of Health (NIH)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Center Core Grants (P30)
Project #
Application #
Study Section
Special Emphasis Panel (ZDK1-GRB-S)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Michigan Ann Arbor
Ann Arbor
United States
Zip Code
Zeng, Lixia; Mathew, Anna V; Byun, Jaeman et al. (2018) Myeloperoxidase-derived oxidants damage artery wall proteins in an animal model of chronic kidney disease-accelerated atherosclerosis. J Biol Chem 293:7238-7249
Jadoon, Adil; Mathew, Anna V; Byun, Jaeman et al. (2018) Gut Microbial Product Predicts Cardiovascular Risk in Chronic Kidney Disease Patients. Am J Nephrol 48:269-277
Nielsen, Jonas B; Fritsche, Lars G; Zhou, Wei et al. (2018) Genome-wide Study of Atrial Fibrillation Identifies Seven Risk Loci and Highlights Biological Pathways and Regulatory Elements Involved in Cardiac Development. Am J Hum Genet 102:103-115
Sahinoz, Melis; Khairi, Shafaq; Cuttitta, Ashley et al. (2018) Potential association of LMNA-associated generalized lipodystrophy with juvenile dermatomyositis. Clin Diabetes Endocrinol 4:6
Fan, Yanbo; Lu, Haocheng; Liang, Wenying et al. (2018) Endothelial TFEB (Transcription Factor EB) Positively Regulates Postischemic Angiogenesis. Circ Res 122:945-957
Ruebsam, Anne; Dulle, Jennifer E; Myers, Angela M et al. (2018) A specific phosphorylation regulates the protective role of ?A-crystallin in diabetes. JCI Insight 3:
An, Duo; Chiu, Alan; Flanders, James A et al. (2018) Designing a retrievable and scalable cell encapsulation device for potential treatment of type 1 diabetes. Proc Natl Acad Sci U S A 115:E263-E272
Turcot, Valérie (see original citation for additional authors) (2018) Protein-altering variants associated with body mass index implicate pathways that control energy intake and expenditure in obesity. Nat Genet 50:26-41
Harvey, Innocence; Stephenson, Erin J; Redd, JeAnna R et al. (2018) Glucocorticoid-Induced Metabolic Disturbances Are Exacerbated in Obese Male Mice. Endocrinology 159:2275-2287
Callaghan, Brian C; Xia, Rong; Reynolds, Evan et al. (2018) Better diagnostic accuracy of neuropathy in obesity: A new challenge for neurologists. Clin Neurophysiol 129:654-662

Showing the most recent 10 out of 1823 publications